Pfizer To Test COVID-19 Vaccine

Pfizer To Test COVID-19 Vaccine In Larger Group Of Children Below 12

Read Time:1 Minute, 34 Second

Preparations are now being made to bring the corona vaccine to children below the age of 12 in the world. America’s giant Pfizer, which makes a vaccine against the coronavirus, has said that it is going to start trials of its vaccine on children under the age of 12, under which a small number of young children in the first phase of the trial. Will be given different doses of Pfizer’s corona vaccine. For this, Pfizer will select more than 4,500 children at more than 90 clinical sites in four countries – the United States, Finland, Poland, and Spain.

Pfizer said that the work of enrolling children between the ages of five and 11 years will begin this week for clinical trials of the vaccine. These children will be given two vaccine doses of 10 micrograms, which is one-third of the vaccine dose given to adolescents (between 12 and 18 years) and adults. Pfizer said that a few weeks later, a clinical trial of the vaccine will be started on children older than 6 months and they will be given a three microgram vaccine dose.

When will this vaccine come?

A Pfizer spokesperson said that the company expects the vaccine trial data on children aged 5 to 11 years to come by September, while for children aged 2 to 5 years, this figure may come soon, after which The company will apply for the emergency use of this vaccine.

Vaccines already being administered to children above 12 years of age

The use of the vaccine has already been approved for children over the age of 12. In the US and the European Union, Pfizer’s vaccine has already been approved for children over the age of 12, although this approval has been given for emergency use only. Children in this age group are being given the same dosage as adults i.e. 30 micrograms.

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %